Australian Capital Territory Numbered Acts

[Index] [Table] [Search] [Search this Act] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

POISONS AND DRUGS (AMENDMENT) ACT 1991 (NO. 4 OF 1991) - SCHEDULE 4

    SCHEDULE 4     Section 3

Acebutolol

Acepifylline, except when included in Schedule 3

Acepromazine

Acetanilide and alkyl acetanilides, for human therapeutic use

Acetazolamide

Acetohexamide

Acetylcholine

Acetylcysteine

Acetyldihydrocodeine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of acetyldihydrocodeine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine

Acetylmethyldimethyloximidophenylhydrazine

Actinomycin D (dactinomycin)

Acyclovir

Adiphenine

Adrenaline, except—

        (a)     when included in Schedule 3; or

        (b)     in preparations containing 0.02% or less of adrenaline

Alclometasone

Alcuronium salts

Allopurinol

Allyloestrenol

Alphadolone

Alphaxalone

Alprazolam

Alprenolol

Alprostadil

Amantadine

Ambenonium

Ambucetamide

Ambutonium

Amethocaine

Amikacin

Amiloride

3-Aminobenzoic acid ethyl ester methanesulphonate

Aminocaproic acid

Aminoglutethimide

Aminometradine

Aminophenazone and its derivatives, for the treatment of animals

Aminophylline, except when included in Schedule 3

Aminopterin

4-Aminopyridine

Aminorex

Aminosalicylic acid

Amiodarone

Amiphenazole

Amisometradine

Amitriptyline

Amodiaquine

Amoxycillin

Amphomycin

Amphotericin

Ampicillin

Amsacrine

Amylobarbitone when packed and labelled for injection

Amylocaine

Anabolic steroidal agents, except when separately specified in these Schedules

Angiotensin amide

Antazoline, except when included in Schedule 2

Antibiotics, except—

        (a)     when separately specified in these Schedules; or

        (b)     nisin

Antigens for human therapeutic use

Antihistamines, except—

        (a)     when included in Schedule 2 or 3; or

        (b)     when separately specified in this Schedule

Antimony organic compounds for therapeutic use

Apomorphine

Aprotinin

Arsenic— see Thiacetarsamide

Aspirin—

        (a)     when combined with caffeine, paracetamol or salicylamide or any derivative of these substances; or

        (b)     for injection

Astemizole

Atenolol

Atracurium besylate

Atropine, except when included in Schedule 2

Auranofin

Avoparcin, except when packed and labelled for use as an animal feed additive

Azaperone

Azapetine

Azatadine, except when included in Schedule 3

Azlocillin

Aztreonam

Bacampicillin

Bacitracin, except—

        (a)     when included in Schedule 6;

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

        (c)     in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Baclofen

Bamipine

Barbiturates, except when separately specified in these Schedules

Beclamide

Belladonna, except when included in Schedule 2

Bemegride

Benactyzine and other substances structurally derived from diphenylmethane with ataractic properties when used for therapeutic purposes

Bendrofluazide

Benorylate

Benserazide

Benzamine, except when included in Schedule 2

Benzhexol

Benzilonium

Benzocaine, except when included in Schedule 2

Benzodiazepine derivatives, except when separately specified in these Schedules

Benzoyl peroxide in preparations for external human therapeutic use, except when included in Schedule 2 or 3

Benzphetamine

Benztropine

Benzydamine, except when included in Schedule 2

Benzylpenicillin (including procaine penicillin), except when included in Schedule 6

Betahistine

Bethanechol chloride

Bethanidine

Bifonazole

Biperiden

Bismuth compounds for human therapeutic or cosmetic use, except—

        (a)     bismuth citrate when incorporated in hair colourant preparations in concentrations of 0.5% or less;

        (b)     bismuth oxychloride in cosmetics; or

        (c)     bismuth formic iodide or bismuth subiodide in dusting powders containing 3% or less of bismuth

Bleomycin

Boron for human therapeutic use—

        (a)     for internal use

        (b)     in glycerines or honeys of borax or boric acid;

        (c)     in dusting powders for paediatric use; or

        (d)     as a therapeutically active ingredient in other preparations for dermal use except—

              (i)     in antifungal preparations; or

              (ii)     in preparations containing 0.1% or less of boron

Bretylium

Bromazepam

Bromides, inorganic, for therapeutic use

Bromocriptine

Bromoform for therapeutic use

Brompheniramine, except when included in Schedule 2 or 3

Bromvaletone

Buclizine, except when included in Schedule 2 or 3

Bufexamac, except—

        (a)     in preparations for dermal use containing 5% or less of bufexamac; or

        (b)     in suppositories

Bumetanide

Bupivacaine

Buprenorphine

Buspirone

Busulphan

Butacaine

Butylaminobenzoate, except when included in Schedule 2

Butylchloral hydrate

Calcitonin

Calcitriol

Calcium carbimide for therapeutic use

Camphorated oil excluding admixtures

Camphotamide

Candicidin

Canine tick anti-serum

Cantharidin

Capreomycin

Captodiame

Captopril

Capuride

Caramiphen

Carbachol

Carbamazepine

Carbaryl for human therapeutic use, except when included in Schedule 2

Carbazochrome

Carbenicillin

Carbenoxolone, except when included in Schedule 2

Carbidopa

Carbimazole

Carbocromen

Carboplatin

Carbromal

Cardiac glycosides, except when separately specified in these Schedules

Carindacillin

Carmustine

Carnidazole for the treatment of pigeons

Catalin

Cathine

Cefaclor

Cefoperazone

Cefotaxime

Cefotetan

Cefoxitin

Ceftazidime

Ceftriaxone

Cephacetrile

Cephadroxil for the treatment of animals

Cephalexin

Cephaloridine

Cephalothin

Cephamandole

Cephapirin

Cephazolin

Cephradine

Chenodeoxycholic acid

Chloral formamide

Chloral hydrate, except in preparations for topical use containing 2% or less of chloral hydrate

α-Chloralose— see Chloralose

Chloralose, except when included in Schedule 6

Chlorambucil

Chloramphenicol

Chlorazanil

Chlorbutol in preparations for human oral use, except in preparations containing 0.5% or less of chlorbutol as a preservative

Chlorcyclizine

Chlordiazepoxide

Chlormerodrin

Chlormethiazole

Chlormezanone

Chloroform for use in anaesthesia

2-(4-Chlorophenyl)-1,2,4-triazole [5,1a]-isoquinoline for the treatment of animals

Chloroquine

Chlorothiazide

Chlorpheniramine, except when included in Schedule 2 or 3

Chlorphentermine

Chlorpromazine

Chlorpropamide

Chlorprothixene

Chlortetracycline, except when included in Schedule 6

Chlorthalidone

Chlorzoxazone

Cholestyramine for human therapeutic use

Chymopapain, injection for human therapeutic use

Ciclacillin

Cilastatin

Cimetidine

Cinchocaine

Cinoxacin

Ciprofloxacin

Cisapride

Cisplatin

Clanobutin for the treatment of animals

Clavulanic acid

Clemastine, except when included in Schedule 3

Clemizole

Clenbuterol for the treatment of animals

Clidinium

Clindamycin

Clobazam

Clobetasone-17-butyrate

Clofenamide

Clofibrate

Clomiphene

Clomipramine

Clomocycline

Clonazepam

Clonidine

Clopamide

Cloprostenol for the treatment of animals

Clorazepate

Clorexolone

Clorprenaline

Clotrimazole, except when included in Schedule 3 or 6

Cloxacillin

Clozapine

Codeine when compounded with one or more other therapeutically active substances—

        (a)     in divided preparations containing 30 mg or less of codeine per dosage unit; or

        (b)     in undivided preparations containing 1% or less of codeine;

except when included in Schedule 2 or 3

Colaspase

Colchicine

Colestipol for human therapeutic use

Colistin

Cortisone and steroid suprarenal cortical hormones, except hydrocortisone in Schedule 3

Crystal violet for human therapeutic use

Curare

Cyclandelate

Cyclizine

Cyclofenil

Cyclopenthiazide

Cyclopentolate

Cyclophosphamide

Cyclopropane for therapeutic use

Cycloserine

Cyclosporin

Cyclothiazide

Cycrimine

Cyproheptadine, except when included in Schedule 3

Cyproterone

Cytarabine

Dacarbazine

Danazol

Dantrolene

Dapsone

Daunorubicin

Deanol

Debrisoquine

Demecarium bromide

Demeclocycline

Desipramine

Desmopressin (DDAVP)

Detomidine for the treatment of animals

Dexchlorpheniramine, except when included in Schedule 2 or 3

Dexfenfluramine

Dextromethorphan, except when included in Schedule 2

Dextropropoxyphene—

        (a)     in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or

        (b)     in liquid preparations containing 2.5% or less of dextropropoxyphene

Dextrorphan

Diazepam

Diazoxide

Dibenzepin

trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (sputolysin), except when included in Schedule 6

Dichloralphenazone

Dichlorphenamide

Diclofenac

Dicyclomine, except when included in Schedule 2

Dienoestrol

Diethazine

Diethylcarbamazine for human therapeutic use

Diethylpropion

Difenoxin in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin

Diflunisal

Digitalis and its glycosides

Digoxin antibody

Dihydralazine

Dihydrocodeine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine;

    except when included in Schedule 2 or 3

Dihydrostreptomycin, except when included in Schedule 6

Diisopropylamine dichloroacetate

Diltiazem

Dimenhydrinate, except when included in Schedule 2 or 3

Dimethindene, except when included in Schedule 3

Dimethisoquin, except when included in Schedule 2

Dimethoxanate

Dimethyl sulphoxide for therapeutic use, except—

        (a)     when included in Schedule 6; or

        (b)     in in vitro test kits

Dimetridazole

2,4-Dinitrochlorobenzene for therapeutic use

Dinitrocresols for therapeutic use

Dinitronaphthols for therapeutic use

Dinitrophenols for therapeutic use

Dinitrothymols for therapeutic use

Dinoprost

Diperodon

Diphemanil methylsulphate, except when included in Schedule 2

Diphenhydramine, except when included in Schedule 2 or 3

Diphenidol

Diphenoxylate in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate

Diphenylpyraline, except when included in Schedule 2 or 3

Dipivefrin

Dipyridamole

Disophenol

Disopyramide

Distigmine

Disulfiram for therapeutic use

Dithiazanine, except when included in Schedule 6

Dobutamine

Domperidone

Dopamine

Dothiepin

Doxapram

Doxepin

Doxorubicin

Doxycycline

Doxylamine, except when included in Schedule 2 or 3

Droperidol

Drostanolone

Dydrogesterone

Econazole, except when included in Schedule 3 or 6

Edetic acid for human therapeutic use in preparations for injection or infusion

Emetine, except in preparations containing 0.2% or less of emetine

Enalapril

Enflurane for therapeutic use

Ephedrine, except—

        (a)     when included in Schedule 2 or 3;

        (b)     in preparations for topical use containing 1% or less of ephedrine; or

        (c)     for internal use for the relief of respiratory tract conditions only, when compounded with one or more other therapeutically active substances in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Epicillin

Epirubicin

Ergometrine

Ergot

Erythromycin, except—

        (a)     when included in Schedule 6;

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

        (c)     in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Estramustine

Ethacrynic acid

Ethambutol

Ethamivan

Ethchlorvynol

Ether for use in anaesthesia

Ethinamate

Ethinyloestradiol

Ethoglucid

Ethoheptazine, except when included in Schedule 2

Ethopropazine

Ethosuximide

Ethotoin

Ethoxzolamide

Ethyl chloride for inhalation anaesthesia

Ethylmorphine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of ethylmorphine;

except when included in Schedule 2

Ethyloestrenol

Ethynodiol

Etidocaine

Etidronate, except in tooth pastes and gels containing 1% or less of etidronate

Etilefrin hydrochloride

Etoposide

Etretinate

Famotidine

Felodipine

Felypressin

Fencamfamin

Fenfluramine

Fenoprofen

Fenoterol, except when included in Schedule 3

Fenpipramide

Fenpiprane

Fenproporex

Fenprostalene for the treatment of animals

Flavophospholipol, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Flecainide

Flucloxacillin

Flucytosine

Flufenamic acid

Flumazanil

Flunisolide

Flunitrazepam

Flunixin meglumine for the treatment of animals

Fluorides in preparations for human ingestion, except when included in Schedule 2 or 3

Fluorouracil

Fluoxetine

Fluoxymesterone

Fluphenazine

Fluprostenol for the treatment of animals

Flurazepam

Fluroxene for inhalation anaesthesia

Fluspirilene

Follicle-stimulating hormone (animal)

Fosfestrol

Framycetin

Frusemide

Fusidic acid

Galanthamine

Gallamine

Gemeprost

Gentamicin

Glibenclamide

Glibornuride

Gliclazide

Glipizide

Glucagon

Glutethimide

Glyceryl trinintrate in preparations for injection

Glycopyrrolate

Glymidine

Gonadorelin

Gonadotrophins, except when separately specified in this Schedule or in Schedule 2

Goserelin acetate

Gramicidin

Griseofulvin

Growth hormone

Guaiphenesin, except when included in Schedule 2

Guanabenz

Guanacline

Guanethidine

Halcinonide

Haloperidol and other substances structurally derived from butyrophenone with ataractic properties, when used for therapeutic purposes, except when separately specified in this Schedule

Halothane for therapeutic use

Heparin for internal therapeutic use

Hetacillin

Hexachlorophane—

        (a)     in preparations for use on infants; or

        (b)     in other preparations, except when included in Schedule 2 or 6

Hexamethonium

Hexocyclium

Homatropine, except when included in Schedule 2

Hyaluronic acid in preparations for injection

Hydralazine

Hydrochlorothiazide

Hydrocyanic acid for therapeutic use

Hydroflumethiazide

Hydroquinone (other than its alkyl ethers separately specified in this Schedule) in preparations for human therapeutic or cosmetic use, except—

        (a)     when included in Schedule 2; or

        (b)     in hair preparations containing 1% or less of hydroquinone

Hydroxychloroquine

Hydroxyephedrine

Hydroxyprogesterone

Hydroxyurea

Hydroxyzine

Hygromycin, except—

        (a)     when included in Schedule 6; or

        (b)     in preparations in concentrations of 50 mg/kg or less of antibiotic substances

Hyoscine, except when included in Schedule 2

Hyoscyamine, except when included in Schedule 2

Hyoscyamus, except when included in Schedule 2

Hypothalamic releasing factors, except when separately specified in this Schedule

Ibufenac

Ibuprofen, except when included in Schedule 3

Idoxuridine, except when included in Schedule 3

Imipenem

Imipramine

Indapamide

Indomethacin

Inositol nicotinate for internal use

Interferon

Ion-exchange resins, anionic and cationic, for internal use in humans, except when separately specified in this Schedule

Iopamidol

Ipratropium

Iproniazid

Iron compounds in injectable preparations for human therapeutic use

Isoaminile

Isocarboxazid

Isoconazole, except when included in Schedule 3 or 6

Isoetharine

Isoflurane for therapeutic use

Isometheptene

Isoniazid

Isoprenaline

Isopropamide, except when included in Schedule 2

Isotretinoin

Isoxuprine

Ivermectin for the treatment of dogs

Kanamycin

Ketamine

Ketoconazole

Ketoprofen

Khellin

Kitasamycin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds for growth promotion containing 100 mg/kg or less of antibiotic substances

Labetalol

Latamoxef

Laudexium methylsulphate

Lead compounds for human therapeutic use

Lefetamine

Leptazol

Leuprorelin

Levallorphan

Levamisole—

        (a)     for human therapeutic use; or

        (b)     in preparations for the prevention or treatment of heartworm in dogs

Levodopa

Levonorgestrel

Lidoflazine

Lignocaine, except when included in Schedule 2

Lincomycin

Lindane for human therapeutic use, except when included in Schedule 2

Liothyronine sodium (triiodothyronine)

Lithium salts for therapeutic use, except in preparations containing 0.01% or less of lithium

Lobelia, except—

        (a)     when included in Schedule 2; or

        (b)     in preparations for smoking or burning

Lobeline, except—

        (a)     when included in Schedule 2; or

        (b)     in preparations for smoking or burning

Lomustine

Loperamide, except when included in Schedule 3

Lorazepam

Loxapine

Luteinising hormone— see also Gonadotrophins

Lymecycline

Mafenide, except when included in Schedule 6

Maldison for human therapeutic use, except when included in Schedule 2

Maprotiline

Mazindol

Mebeverine

Mebhydrolin

Mecamylamine

Meclofenoxate

Meclozine

Medazepam

Medroxyprogesterone

Mefenamic acid, except when included in Schedule 3

Mefenorex

Mefloquine

Mefruside

Megestrol

Melphalan

Mepacrine

Mepenzolate

Mephenesin

Mephentermine

Mepivacaine

Meprobamate

Mepyramine, except when included in Schedule 3

Mercaptopurine

Mercury for therapeutic use, except when included in Schedule 2 or 6

Mesalazine

Mesterolone

Mestranol

Metaraminol

Metergoline for the treatment of animals

Metformin

Methacycline

Methandienone

Methandriol

Methanthelinium

Methazolamide

Methdilazine, except when included in Schedule 3

Methenolone

Methicillin

Methimazole

Methixene

Methocarbamol

Methotrexate

Methoxsalen

Methoxyflurane for therapeutic use

Methsuximide

Methyclothiazide

Methylandrostanolone

Methyldopa

Methylpentynol and other substituted alkynes for internal use

Methyltestosterone

Methyprylone

Methysergide

Metoclopramide

Metolazone

Metoprolol

Metrizamide

Metronidazole including benzoyl metronidazole

Metyrapone

Mexiletine

Mezlocillin

Mianserin

Mibolerone

Miconazole, except when included in Schedule 2, 3 or 6

Midazolam

Minocycline

Minoxidil

Misoprostol

Mithramycin

Mitobronitol

Mitomycin

Mitozantrone

Monensin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds containing 33 mg/kg or less of antibiotic substances

Monobenzone and other alkyl ethers of hydroquinone for human therapeutic use or cosmetic use

Monoclonal antibodies for therapeutic use, except in diagnostic test kits

Moperone

Mupirocin

Mustine

Nadolol

Nalbuphine

Nalidixic acid, except when included in Schedule 6

Nalorphine

Naloxone

Nandrolone

Naproxen, except when included in Schedule 2

Narasin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds containing 100 mg/kg or less of antibiotic substances

Natamycin

Neomycin, except when included in Schedule 6

Neostigmine

Netilmicin

Nicocodine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of nicocodine

Nicodicodine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of nicodicodine

Nicotine in chewing tablets containing 4 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking, except when included in Schedule 3

Nicotinic acid for human therapeutic use, except—

        (a)     in preparations containing 50 mg or less of nicotinic acid per recommended daily dose; or

        (b)     nicotinamide

Nicotinyl alchohol for internal use

Nicoumalone for internal therapeutic use

Nifedipine

Nifenazone

Nikethamide

Niridazole

Nitrazepam

Nitrofuran and its derivatives for human therapeutic use, except when included in Schedule 3

Nitrous oxide for therapeutic use

Nizatadine

Nomifensine

Noradrenaline, excluding its derivatives

Norcodeine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of norcodeine

Norethandrolone

Norethisterone

Norfloxacin

Nortriptyline

Novobiocin, except when included in Schedule 6

Nystatin, except when included in Schedule 3

Octamylamine

Octatropine

Octreotide

Oestradiol, except when included in Schedule 6

Oestriol

Oestrone

Oleandomycin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Olsalasine sodium

Omeprazole

Opipramol

Orciprenaline

Organophosphorus compounds with anticholinesterase activity for human therapeutic use, except—

        (a)     when included in Schedule 2; or

        (b)     when separately specified in this Schedule

Ornidazole

Ornipressin

Orphenadrine

Orthocaine

Orthopterin

Oxacillin

Oxandrolone

Oxazepam

Oxiconazole

Oxolamine

Oxpentifylline

Oxprenolol

Oxybuprocaine

Oxymesterone

Oxymetholone

Oxyphenbutazone

Oxyphencyclimine

Oxyphenonium

Oxytetracycline, except when included in Schedule 6

Oxytocin

Pamaquine

Pancuronium bromide

Papaverine for injection

Paracetamol when combined with aspirin, caffeine or salicylamide or any derivative of these substances

Paraldehyde

Paromomycin

Pemoline

Pempidine

Penicillamine

Pentamethonium

Penthienate

Pentobarbitone when packed and labelled for injection

Pentolinium

Perhexilene

Pericyazine

Perphenazine

Phenacemide

Phenacetin for therapeutic use

Phenazone, except when included in Schedule 2

Phenazopyridine

Phenelzine

Phenethicillin, except when included in Schedule 6

Phenformin

Phenglutarimide

Phenindione for internal therapeutic use

Pheniramine, except when included in Schedule 2 or 3

Phenoxybenzamine

Phenoxymethylpenicillin, except when included in Schedule 6

Phensuximide

Phentermine

Phenthimentonium

Phentolamine

Phenyapin

Phenylbutazone

Phenylephrine in preparations for human ophthalmic use containing 5% or more of phenylephrine

Phenylpropanolamine, except when included in Schedule 3

Phenyltoloxamine, except when included in Schedule 3

Phenytoin

Pholcodine when compounded with one or more other medicaments—

        (a)     in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or

        (b)     in undivided preparations with a concentration of not more than 2.5% of pholcodine;

except when included in Schedule 2

Physostigmine

Picrotoxin

Pilocarpine, except in preparations containing 0.025% or less of pilocarpine

Pimozide

Pindolol

Pipenzolate

Piperacillin

Piperidolate

Pipobroman

Pipradrol

Pirenzepine

Piroxicam

Pituitary and its extracts and active principles or their synthetic substitutes, except when separately specified in this Schedule

Pizotifen

Podophyllotoxin for human therapeutic use, except when included in Schedule 2 or 3

Podophyllum resin (podophyllin) for human therapeutic use, except when included in Schedule 2 or 3

Polyestradiol

Polymethylene bistrimethyl ammonium compounds

Polymyxin

Polysulphated glycosaminoglycans in preparations for injection, except where otherwise specified in this Schedule

Potassium perchlorate for therapeutic use

Practolol

Pramoxine, except when included in Schedule 2

Prazepam

Praziquantel for human therapeutic use

Prazosin

Pregnenolone acetate, except in preparations for topical use

Prenylamine

Prilocaine

Primaquine

Primidone

Probenecid

Probucol

Procainamide

Procaine

Procarbazine

Prochlorperazine

Procyclidine, except when included in Schedule 2

Progesterone, except when included in Schedule 6

Proguanil

Prolintane

Promazine

Promethazine, except when included in Schedule 2 or 3

Propanidid

Propantheline, except when included in Schedule 2

Propofol

Propoxur for human therapeutic use

Propranolol

Propylhexedrine

Propylthiouracil

Propyphenazone

Proquazone

Prostaglandins, except where separately specified in this Schedule

Prostianol for the treatment of animals

Prothionamide

Protirelin (thyrotrophin releasing factor)

Protriptyline

Proxymetacaine

Pseudoephedrine in preparations for stimulant, appetite suppression or weight control purposes

Pyrazinamide

Pyridostigmine

Pyridoxine hydrochloride in preparations for human use containing more than 50 mg of pyridoxine per recommended daily dose, unless labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”; or

“WARNING—THIS PRODUCT CONTAINS PYRIDOXINE HYDROCHLORIDE WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”

Pyrimethamine

Pyrovalerone

Quinethazone

Quinidine

Ranitidine

Rauwolfia serpentina

Ribavirin

Rifampicin

Rimiterol hydrobromide

Ritodrine

Rolitetracycline

Rosoxacin

Salbutamol, except when included in Schedule 3

Salicylamide when combined with aspirin, caffeine or paracetamol or any derivative of these substances

Salinomycin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds containing 60 mg/kg or less of antibiotic substances

Selenium for therapeutic use, except—

        (a)     when included in Schedule 5 or 6;

        (b)     as elemental selenium in pellets containing 50 mg/kg or less of selenium for the treatment of animals;

        (c)     in tablets, for the treatment of animals, each—

              (i)     weighing 2 g or more; and

              (ii)     containing 30 micrograms or less of selenium; or

        (d)     in animal feeds containing 0.1 g/tonne or less of selenium

Semisodium valproate

Sera for human therapeutic use

Sermorelin

Sex hormones and all substances having sex hormonal activity, except when separately specified in these Schedules

Silver sulphadiazine

Sisomycin

Sodium cellulose phosphate for human internal use

Sodium cromoglycate, except when included in Schedule 2

Sodium nitroprusside for human therapeutic use

Sodium pentosan polysulphate for the treatment of animals

Sodium valproate

Sontoquine

Sotalol

Sparteine

Spectinomycin

Spiramycin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds for growth promotion in pigs or poultry containing 50 mg/kg or less of antibiotic substances

Spironolactone

Sputolysin— see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate

Stanolone

Stanozolol

Stilboestrol

Stramonium, except—

        (a)     when included in Schedule 2; or

        (b)     in preparations for smoking or burning

Streptomycin, except when included in Schedule 6

Strophanthus and its glycosides

Strychnine in preparations containing 1.5% or less of strychnine for the treatment of animals

Sulfadoxine

Sulphametrole

Sulindac

Sulphatroxazole for the treatment of animals

Sulphinpyrazone

Sulphomyxin

Sulphonal and alkyl sulphonals

Sulphonamides, except—

        (a)     when included in Schedule 6;

        (b)     when separately specified in this Schedule;

        (c)     oryzalin;

        (d)     sulphaquinoxaline in animal feeds containing 200 mg/kg or less of sulphaquinoxaline; or

        (e)     sulphaquinoxaline when incorporated in baits for the destruction of vermin

Sulthiame

Suxamethonium salts

Tacrine

Tamoxifen

Temazepam

Teniposide

Tenoxicam

Terbutaline, except when included in Schedule 3

Terfenadine, except when included in Schedule 3

Teropterin

Testosterone, except when included in Schedule 6

Tetrabenazine

Tetracosactrin

Tetracycline, except when included in Schedule 6

Thalidomide

Thenyldiamine, except when included in Schedule 2 or 3

Theophylline, except when included in Schedule 3

Thiacetarsamide in preparations for the prevention or treatment of heart worm in dogs

Thiacetazone

Thiambutosine

Thiazosulphone

Thiethylperazine

Thioguanine

Thiopropazate

Thioridazine

Thiotepa

Thiothixene

Thiouracil

Thiourea for therapeutic use

Thyroid and its extracts and active principles, except when separately specified in this Schedule

Thyrotrophin (TSH)

Thyroxine sodium

Tiamulin, except—

        (a)     when included in Schedule 6; or

        (b)     in prepared animal feeds

Ticarcillin

Tiemonium

Tigloidine

Tiletamine for the treatment of animals

Timolol

Tinidazole

Tioconazole, except when included in Schedule 3

Tipepidine

Tobramycin

Tocainide

Tolazamide

Tolazoline for internal use

Tolbutamide

Tolpropamine

Toxoids for human therapeutic use

Tranexamic acid

Tranylcypromine

Tretamine

Triamterene

Triaziquone

Triazolam

Trichloroethylene for therapeutic use

Triclofos

Tricyclamol

Tridihexethyl

Trifluoperazine

Trifluperidol

Trimeprazine, except when included in Schedule 2 or 3

Trimetaphan

Trimethoprim

Trimipramine

Trimustine

Trioxysalen

Tripelennamine

Triprolidine, except when included in Schedule 2 or 3

Tropicamide

Troxidone

Tubocurarine

Tulobuterol

Tylosin, except—

        (a)     when included in Schedule 6;

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

        (c)     in milk replacers for calves or starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Urethane, excluding its derivatives, for therapeutic use

Urofollitrophin (human follicle-stimulating hormone)

Vaccines for human therapeutic use

Vaccines, veterinary live virus, except—

        (a)     poultry vaccines;

        (b)     pigeon pox vaccine; or

        (c)     scabby mouth vaccine

Valnoctamide

Vancomycin

Vasopressin

Vecuronium bromide

Verapamil

Veratrum

Vidarabine

Vinblastine

Vincristine

Vindesine

Viprynium

Virginiamycin, except—

        (a)     when included in Schedule 6; or

        (b)     in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Visnadine

Vitamin A for human therapeutic use, except in preparations containing 10 000 I.U. or less of vitamin A per recommended daily dosage

Vitamin D for human therapeutic use, except in preparations containing 25 micrograms or less of vitamin D per recommended daily dosage

Warfarin for internal therapeutic use

Xanthinol nicotinate

Xylazine

Yohimbine

Zeranol, except when included in Schedule 6

Zidovudine

Zinc compounds for human internal use, except—

        (a)     in preparations with a recommended daily dose of 25 mg or less of zinc; or

        (b)     in preparations with a recommended daily dose of more than 25 mg but not more than 50 mg of zinc when the pack is labelled—

        “WARNING—MAY BE DANGEROUS IF TAKEN IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

        “WARNING—CONTAINS ZINC, WHICH MAY BE DANGEROUS IF TAKEN IN LARGE AMOUNTS OR FOR A LONG PERIOD”

Zolazepam for the treatment of animals



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback